The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity on Diabetic Patients

The incidence of DM is unclear in RA but most prior data suggest that DM or insulin resistance in RA has risen because of activation of the immune system and/or RA therapy .

Besides, RA causes joints to become stiff, swollen, and agonizing. As a result, the patient may not want to exercise or move. One study found that 42% of people with RA are not physically active. the aim of this study is To evaluate the glycemic status among RA patients with Type 2 diabetes and its association with disease activity.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Rheumatoid Arthritis (RA Arthritis Arthritis, Rheumatoid Autoimmune Diseases Connective Tissue Diseases Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Joint Diseases Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases Rheumatic Diseases Skin and Connective Tissue Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Assiut university

Asyut, Egypt

About this study

Taking the potential link between DM and RA into consideration, detection and control of DM will significantly increase prolonged prognosis and therefore decrease the economic burden of RA patients and death rate. The aim of this research is to examine diabetic RA's glycemic status and to assess the relationship between RA and DM's clinical characteristics as well as the therapy response in RA patients with diagnosed DM. Keeping an eye on glycemic control in RA patients could prevent metabolic and cardiovascular comorbidities in those susceptible patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

type 2 diabetic patients
rheumatoid arthritis patients

Exclusion criteria

gestional diabetes
type 1 diabetic patients

Treatment and study plan

Primary outcomes

Fasting blood glucose

Time frame: baseline

correlation between type 2 diabetes control and rheumatoid arthritis activity

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed khedr Nady

CONTACT

[email protected]

+201097613616

Eman Mohamed Ibrahim, Lecturer

CONTACT

[email protected]

+201007179120

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

The Impact of Glycemic Control on Rheumatoid Arthritis Disease Activity in Diabetic Patients

Important dates

Study start: 2024
Primary completion: 2026
Study completion: 2027
First posted: Nov 18, 2024
Registry last updated: Nov 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting